Cristcot

Knowledge is power, and sharing what we know about the struggles patients go through can help spread awareness about IBD. While abdominal pain and bowel urgency are among the most common symptoms, patients can also experience joint pain, fatigue, and other symptoms and complications that affect daily life. To learn more about World IBD Day and the affects it can have on patients visit https://lnkd.in/ebWSZFh4 #UnobtrusiveCare #CristcotConnects #WorldIBDDAY

We are proud to welcome the newest additions to our team! Their passion and expertise will help drive our growth and support Cristcot's ongoing mission. If you are interested in joining our growing team, explore our open positions here: https://lnkd.in/epiSP5KF #UnobtrusiveCare #CristcotCareers #CristcotConnects

Cristcot would like to wish all who celebrate a Happy Mother’s Day. We are truly grateful for all the dedication, sacrifice and care you give. Wishing you a day filled with the rest, joy, and appreciation you so deeply deserve. #UnobtrusiveCare #CristcotConnects #MothersDay

Cristcot Appoints Rayna Herman as President of its Hydrocortisone Acetate Division Ms. Herman is a life sciences executive with extensive experience developing commercialization strategies and building commercial teams. View the press release here: https://lnkd.in/e9EtKn5z #UnobtrusiveCare #CristcotConnects

You’re invited to our oral presentation: Surreptitious Corticosteroid Use Identified by Formal Pharmacokinetic and HPA-Axis Testing in a Phase 3 Ulcerative Colitis Clinical Trial Session. ·        Presented by Parambir S. Dulai, MD ·        Session: IBD: Controlled Clinical Trials 2 (8:00-9:30 am) ·        Location: Skyline Ballroom (W375c) Visit our website https://lnkd.in/g2SaDtdP, to learn more about our Science and our commitment to patients living with Ulcerative Colitis. #UnobtrusiveCare #DDW2026 #CristcotCongress #CristcotConnects

Cristcot to Present Oral Abstract at 2026 Digestive Disease Week (DDW) Oral presentation on the impact of concomitant steroid use in ulcerative colitis (UC) scheduled for May 5, 2026, at 9:15am CDT View the press release here: https://lnkd.in/ejxB9CQA

We are thrilled to welcome our newest team members to the Cristcot family! Just like spring blooms, they are bringing fresh energy and expertise to help us grow and advance Cristcot’s mission. If you would like to join our growing team, view our open positions here: https://lnkd.in/epiSP5KF #UnobtrusiveCare #CristcotCareers #CristcotConnects

We are excited to introduce new members of our growing Field Medical Affairs team at Cristcot! ✳️ Elisabeth Evans, MSN, FNP – Medical Science Liaison, Southwest ✳️ Josh Rancourt, Sr. Director, Field Medical Affairs ✳️ Michael Samaras, PhD – Regional Director, Field Medical Excellence West ✳️ Anne Sullivan, CNP – Medical Science Liaison, Northwest ✳️ William Sypula, PharmD – Regional Director, Field Medical Excellence East ✳️ Tracy Wilson, DNP, MBe, MSN, APRN, FAANP, FADLN, FNAP – Medical Science Liaison, South Central Our team is looking forward to connecting with the IBD community at DDW in Chicago, May 2–5. Elisabeth, Josh, Michael, and William will be at booth #2557. Come by to learn more about our commitment to patients living with Ulcerative Colitis. #UnobtrusiveCare #DDW2026 #CristcotCongress #CristcotConnects

Cristcot Announces FDA Acceptance of NDA for Next-Generation Hydrocortisone Acetate (ngHCA) for Treatment of Ulcerative Colitis (UC) of the Rectum Read full press release: www.cristcot.com/news #UnobtrusiveCare #CristcotConnects #CristcotNews

April is IBS Awareness Month, and Cristcot stands in solidarity with the millions of people worldwide living with inflammatory bowel disease. We recognize the daily challenges, courage, and resilience of the IBS community. Learn more about Cristcot here: https://cristcot.com #UnobtrusiveCare #CristcotConnects #IBSAwarenessMonth #ThisIsIBS